Summary
63 / 100 · Bulios Score
What speaks for it
- Revenue grew by 19% a year over the last 3 years.
- It has raised its dividend 9 years in a row and pays out only 4.0% of profit.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 26.6 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 16% a year over 5 years. Over the last 3 years it grew by 19% a year. Earnings per share grew by 14% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 86 USD
- Sales and administration 5.6 USD
- Taxes and other 1.6 USD
- Net profit 6.9 USD
Net profit, industry median (Medical - Care Facilities) 6.7 USD
Out of every 100 USD of revenue, 6.9 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 5.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.15%
- Paid out of profit
- 4.0%
- Raised in a row
- 9 years
You receive $0.26 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 2
- Sell 2
Today's price within the analysts' price targets
The average target of $215 is 24% above today's price. 69% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Skilled Services Segment 97%
- Standard Bearer Segment 2.6%
By region
- All Other 100%
Skilled Services Segment brings in 97% of revenue.
Segments in detail